anastrozole has been researched along with Innate Inflammatory Response in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Anastrozole is a selective aromatase inhibitor and is used for the hormonal treatment of postmenopausal breast cancer." | 7.74 | Anastrozole-associated sclerosing glomerulonephritis in a patient with breast cancer. ( Akgul, B; Camci, C; Kalender, ME; Karakok, M; Sevinc, A; Turk, HM, 2007) |
| "We diagnosed it as inflammatory breast cancer with positive hormone receptor (ER+, PgR+) and unexpression of HER2 (HercepTest 1 +)." | 5.35 | [A case of inflammatory breast cancer responding to anastrozole]. ( Kubota, K; Kuwayama, T; Nakagawa, T; Sato, T; Sugihara, K; Suzuki, S, 2009) |
| "Use of aromatase inhibitors (AIs), exemestane, letrozole and anastrozole, for breast cancer therapy is associated with severe pain symptoms, the underlying mechanism of which is unknown." | 3.80 | Steroidal and non-steroidal third-generation aromatase inhibitors induce pain-like symptoms via TRPA1. ( Benemei, S; Coppi, E; De Logu, F; Di Tommaso, MR; Fusi, C; Geppetti, P; Marone, IM; Materazzi, S; Minocci, D; Moneti, G; Nassini, R; Pieraccini, G; Susini, T; Trevisan, G; Tuccinardi, T, 2014) |
| "Anastrozole is a selective aromatase inhibitor and is used for the hormonal treatment of postmenopausal breast cancer." | 3.74 | Anastrozole-associated sclerosing glomerulonephritis in a patient with breast cancer. ( Akgul, B; Camci, C; Kalender, ME; Karakok, M; Sevinc, A; Turk, HM, 2007) |
| "Chronic inflammation is known to promote carcinogenesis; Dicer heterozygous mice are more likely to develop colitis-associated tumors." | 1.56 | Rescuing Dicer expression in inflamed colon tissues alleviates colitis and prevents colitis-associated tumorigenesis. ( Chen, X; Gao, J; He, Q; He, ZW; Jin, Y; Lei, Y; Liu, H; Ou, R; Song, G; Tang, KF; Wang, WY; Wang, Z; Wei, LJ; Wu, X; Xu, Y; Yang, W; Zhang, Z; Zhong, S; Zhou, L, 2020) |
| "We diagnosed it as inflammatory breast cancer with positive hormone receptor (ER+, PgR+) and unexpression of HER2 (HercepTest 1 +)." | 1.35 | [A case of inflammatory breast cancer responding to anastrozole]. ( Kubota, K; Kuwayama, T; Nakagawa, T; Sato, T; Sugihara, K; Suzuki, S, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, X | 1 |
| Chen, X | 1 |
| Liu, H | 1 |
| He, ZW | 1 |
| Wang, Z | 1 |
| Wei, LJ | 1 |
| Wang, WY | 1 |
| Zhong, S | 1 |
| He, Q | 1 |
| Zhang, Z | 1 |
| Ou, R | 1 |
| Gao, J | 1 |
| Lei, Y | 1 |
| Yang, W | 1 |
| Song, G | 1 |
| Jin, Y | 1 |
| Zhou, L | 1 |
| Xu, Y | 1 |
| Tang, KF | 1 |
| Fusi, C | 1 |
| Materazzi, S | 1 |
| Benemei, S | 1 |
| Coppi, E | 1 |
| Trevisan, G | 1 |
| Marone, IM | 1 |
| Minocci, D | 1 |
| De Logu, F | 1 |
| Tuccinardi, T | 1 |
| Di Tommaso, MR | 1 |
| Susini, T | 1 |
| Moneti, G | 1 |
| Pieraccini, G | 1 |
| Geppetti, P | 1 |
| Nassini, R | 1 |
| Kalender, ME | 1 |
| Sevinc, A | 1 |
| Camci, C | 1 |
| Turk, HM | 1 |
| Karakok, M | 1 |
| Akgul, B | 1 |
| Sato, T | 1 |
| Nakagawa, T | 1 |
| Kuwayama, T | 1 |
| Kubota, K | 1 |
| Suzuki, S | 1 |
| Sugihara, K | 1 |
4 other studies available for anastrozole and Innate Inflammatory Response
| Article | Year |
|---|---|
Rescuing Dicer expression in inflamed colon tissues alleviates colitis and prevents colitis-associated tumorigenesis.
Topics: Anastrozole; Animals; Berberine; Carcinogenesis; Cell Line, Tumor; Cell Transformation, Neoplastic; | 2020 |
Steroidal and non-steroidal third-generation aromatase inhibitors induce pain-like symptoms via TRPA1.
Topics: Anastrozole; Androstadienes; Animals; Aromatase Inhibitors; Behavior, Animal; Calcium; Calcium Chann | 2014 |
Anastrozole-associated sclerosing glomerulonephritis in a patient with breast cancer.
Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Atrophy; Breast Neoplasms; Fatal Outcome; Female | 2007 |
[A case of inflammatory breast cancer responding to anastrozole].
Topics: Adenocarcinoma, Scirrhous; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Fem | 2009 |